Worldwide, Gynecological malignancies are an important cause of cancer-related death. The annual estimated incidence is exceeding than 3.6 million and themortality over 1.3 million, they represent nearly 40% of all malignancy incidence and conjointly exceed 30% of all cancer mortality in women. One of the major prognostic factors is nodal involvement in gynecological carcinomas because it is associate with poor outcome and exert influence on treatment modalities. Imaging modalities for LN evaluation in gynecologic malignancies that are the most used are CT and MRI. They are based on morphologic criteria to differentiate benign from malignant lymph node (location, number, size, shape, outline, internal architecture) and degree of uptake in dynamic sequence (contrast enhanced CT and MRI). Nevertheless, they frequently fail to notice metastatic nodes. Ultrasonography can help to differentiate between normal, reactive (immunological state but still benign) and metastatic lymph nodes.
AIM OF THE WORK:
The aim of this study was to evaluate ultrasound accuracy in detection of lymph node affection in gynecologic cancer patients in comparison to the standard studies using CT or MRI and histopathology.